Effects of genistein administration on cytokine induction in whole-body gamma irradiated mice

International Immunopharmacology

Volumn 9, Issue 12, 2009, Pages 1401-1410

  Singh, Vijay K ^a,b   Grace, Marcy B ^b   Parekh, Vaishali I ^b   Whitnall, Mark H ^b   Landauer, Michael R ^b  

^a Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Cytokine array; Cytokines; G CSF; Genistein; Luminex; Radiation injury; RT PCR

Indexed keywords

GAMMA INTERFERON; GENISTEIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 6; THROMBOPOIETIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; GAMMA IRRADIATION; HEMATOPOIETIC CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIATION PROTECTION; SINGLE DRUG DOSE; SPLEEN; WHOLE BODY RADIATION;

ANIMALS; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENISTEIN; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIESIS; HUMANS; INTERLEUKIN-6; MICE; MICE, INBRED STRAINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RADIATION INJURIES; RADIATION-PROTECTIVE AGENTS; WHOLE-BODY IRRADIATION;

EID: 70349423392     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2009.08.012     Document Type: Article

References (65)

1. Waselenko J.K., MacVittie T.J., Blakely W.F., Pesik N., Wiley A.L., Dickerson W.E., et al. Medical management of the acute radiation syndrome: recommendations of the Strategic National Stockpile Radiation Working Group. Ann Intern Med 140 (2004) 1037-1051
2. Pellmar T.C., and Rockwell S. Priority list of research areas for radiological nuclear threat countermeasures. Radiat Res 163 (2005) 115-123
3. Singh V.K., and Seed T.M. Radiation Effects. In: Roy M.J. (Ed). Physician's guide to terrorist attack (2003), Humana Press, Totowa 339-362
4. Xiao M., and Whitnall M.H. Pharmacological countermeasures for the acute radiation syndrome. Curr Mol Pharmacol 2 (2009) 122-133
5. Weiss J.F., and Landauer M.R. History and development of radiation-protective agents. Int J Radiat Biol 85 (2009) 539-573
6. Nair C.K., Parida D.K., and Nomura T. Radioprotectors in radiotherapy. J Radiat Res (Tokyo) 42 (2001) 21-37
7. Setchell K.D. Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 68 (1998) 1333S-1346S
8. Dixon R.A., and Ferreira D. Genistein. Phytochemistry 60 (2002) 205-211
9. Yashar C.M., Spanos W.J., Taylor D.D., and Gercel-Taylor C. Potentiation of the radiation effect with genistein in cervical cancer cells. Gynecol Oncol 99 (2005) 199-205
10. Masai M., Abe K., Akimoto S., Yatani R., and Shimazaki J. Argyrophilic nucleolar organizer regions in benign hyperplastic and cancerous human prostates. Prostate 20 (1992) 1-13
11. Lamartiniere C.A., Moore J.B., Brown N.M., Thompson R., Hardin M.J., and Barnes S. Genistein suppresses mammary cancer in rats. Carcinogenesis 16 (1995) 2833-2840
12. Hong H., Landauer M.R., Foriska M.A., and Ledney G.D. Antibacterial activity of the soy isoflavone genistein. J Basic Microbiol 46 (2006) 329-335
13. Markovits J., Linassier C., Fosse P., Couprie J., Pierre J., Jacquemin-Sablon A., et al. Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res 49 (1989) 5111-5117
14. Fotsis T., Pepper M., Adlercreutz H., Hase T., Montesano R., and Schweigerer L. Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. J Nutr 125 (1995) 790S-797S
15. Wei H., Bowen R., Cai Q., Barnes S., and Wang Y. Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc Soc Exp Biol Med 208 (1995) 124-130
16. Wang Y., Zhang X., Lebwohl M., DeLeo V., and Wei H. Inhibition of ultraviolet B (UVB)-induced c-fos and c-jun expression in vivo by a tyrosine kinase inhibitor genistein. Carcinogenesis 19 (1998) 649-654
17. Hillman G.G., Forman J.D., Kucuk O., Yudelev M., Maughan R.L., Rubio J., et al. Genistein potentiates the radiation effect on prostate carcinoma cells. Clin Cancer Res 7 (2001) 382-390
18. Akimoto T., Nonaka T., Ishikawa H., Sakurai H., Saitoh J.I., Takahashi T., et al. Genistein, a tyrosine kinase inhibitor, enhanced radiosensitivity in human esophageal cancer cell lines in vitro: possible involvement of inhibition of survival signal transduction pathways. Int J Radiat Oncol Biol Phys 50 (2001) 195-201
19. Day R.M., Barshishat-Kupper M., Mog S.R., McCart E.A., Prasanna P.G., Davis T.A., et al. Genistein protects against biomarkers of delayed lung sequelae in mice surviving high-dose total body irradiation. J Radiat Res (Tokyo) 49 (2008) 361-372
20. Landauer M.R., Srinivasan V., and Seed T.M. Genistein treatment protects mice from ionizing radiation injury. J Appl Toxicol 23 (2003) 379-385
21. Davis T.A., Clarke T.K., Mog S.R., and Landauer M.R. Subcutaneous administration of genistein prior to lethal irradiation supports multilineage, hematopoietic progenitor cell recovery and survival. Int J Radiat Biol 83 (2007) 141-151
22. Davis T.A., Mungunsukh O., Zins S., Day R.M., and Landauer M.R. Genistein induces radioprotection by hematopoietic stem cell quiescence. Int J Radiat Biol 84 (2008) 713-726
23. Percy D.H., and Barthold S. Pathology of laboratory rodents and rabbits (2007), Blackwell Publishing, Iowa State University, Ames, Iowa
24. Whitnall M.H., Elliott T.B., Harding R.A., Inal C.E., Landauer M.R., Wilhelmsen C.L., et al. Androstenediol stimulates myelopoiesis and enhances resistance to infection in gamma-irradiated mice. Int J Immunopharmacol 22 (2000) 1-14
25. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 (1987) 156-159
26. Grace M.B., McLeland C.B., and Blakely W.F. Real-time quantitative RT-PCR assay of GADD45 gene expression changes as a biomarker for radiation biodosimetry. Int J Radiat Biol 78 (2002) 1011-1021
27. Grace M.B., McLeland C.B., Gagliardi S.J., Smith J.M., Jackson III W.E., and Blakely W.F. Development and assessment of a quantitative reverse transcription-PCR assay for simultaneous measurement of four amplicons. Clin Chem 49 (2003) 1467-1475
28. Arroyo C.M., Burman D.L., Kahler D.W., Nelson M.R., Corun C.M., Guzman J.J., et al. TNF-alpha expression patterns as potential molecular biomarker for human skin cells exposed to vesicant chemical warfare agents: sulfur mustard (HD) and Lewisite (L). Cell Biol Toxicol 20 (2004) 345-359
29. Singh V.K., Shafran R.L., Inal C.E., Jackson III W.E., and Whitnall M.H. Effects of whole-body gamma irradiation and 5-androstenediol administration on serum G-CSF. Immunopharmacol Immunotoxicol 27 (2005) 521-534
30. Xu Y., Kulkosky J., Acheampong E., Nunnari G., Sullivan J., and Pomerantz R.J. HIV-1-mediated apoptosis of neuronal cells: proximal molecular mechanisms of HIV-1-induced encephalopathy. Proc Natl Acad Sci U S A 101 (2004) 7070-7075
31. Patel R.P., Boersma B.J., Crawford J.H., Hogg N., Kirk M., Kalyanaraman B., et al. Antioxidant mechanisms of isoflavones in lipid systems: paradoxical effects of peroxyl radical scavenging. Free Radic Biol Med 31 (2001) 1570-1581
32. Kruk I., Aboul-Enein H.Y., Michalska T., Lichszteld K., and Kladna A. Scavenging of reactive oxygen species by the plant phenols genistein and oleuropein. Luminescence 20 (2005) 81-89
33. Singh V.K., and Yadav V.S. Role of cytokines and growth factors in radioprotection. Exp Mol Pathol 78 (2005) 156-169
34. Neta R., Abrams J.S., Perlstein R.S., Rokita H., Sipe J.D., Voget S.N., et al. Interactions of the cytokines IL-1, and IL-6 in in vivo host responses. In: Revel M. (Ed). Physiopathology and Clinical Potentials (1992), Raven Press, New York 195-202
35. MacVittie T.J., Monroy R.L., Patchen M.L., and Souza L.M. Therapeutic use of recombinant human G-CSF (rhG-CSF) in a canine model of sublethal and lethal whole-body irradiation. Int J Radiat Biol 57 (1990) 723-736
36. Schuening F.G., Storb R., Goehle S., Graham T.C., Appelbaum F.R., Hackman R., et al. Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis of normal dogs and on hematopoietic recovery after otherwise lethal total body irradiation. Blood 74 (1989) 1308-1313
37. Drouet M., Mourcin F., Grenier N., Leroux V., Denis J., Mayol J.F., et al. Single administration of stem cell factor, FLT-3 ligand, megakaryocyte growth and development factor, and interleukin-3 in combination soon after irradiation prevents nonhuman primates from myelosuppression: long-term follow-up of hematopoiesis. Blood 103 (2004) 878-885
38. Dale D.C. Colony-stimulating factors for the management of neutropenia in cancer patients. Drugs 62 Suppl 1 (2002) 1-15
39. Bociek R.G., and Armitage J.O. Hematopoietic growth factors. CA Cancer J Clin 46 (1996) 165-184
40. Gerber A., Struy H., Weiss G., Lippert H., Ansorge S., and Schulz H.U. Effect of granulocyte colony-stimulating factor treatment on ex vivo neutrophil functions in nonneutropenic surgical intensive care patients. J Interferon Cytokine Res 20 (2000) 1083-1090
41. Ishikawa K., Tanaka H., Matsuoka T., Shimazu T., Yoshioka T., and Sugimoto H. Recombinant human granulocyte colony-stimulating factor attenuates inflammatory responses in septic patients with neutropenia. J Trauma 44 (1998) 1047-1054 (discussion 1054-1055)
42. Wenisch C., Werkgartner T., Sailer H., Patruta S., Krause R., Daxboeck F., et al. Effect of preoperative prophylaxis with filgrastim in cancer neck dissection. Eur J Clin Invest 30 (2000) 460-466
43. Chuang P.I., Yee E., Karsan A., Winn R.K., and Harlan J.M. A1 is a constitutive and inducible Bcl-2 homologue in mature human neutrophils. Biochem Biophys Res Commun 249 (1998) 361-365
44. Lieschke G.J., Grail D., Hodgson G., Metcalf D., Stanley E., Cheers C., et al. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 84 (1994) 1737-1746
45. Ikebuchi K., Clark S.C., Ihle J.N., Souza L.M., and Ogawa M. Granulocyte colony-stimulating factor enhances interleukin 3-dependent proliferation of multipotential hemopoietic progenitors. Proc Natl Acad Sci U S A 85 (1988) 3445-3449
46. Peterson V.M., Adamovicz J.J., Elliott T.B., Moore M.M., Madonna G.S., Jackson III W.E., et al. Gene expression of hematoregulatory cytokines is elevated endogenously after sublethal gamma irradiation and is differentially enhanced by therapeutic administration of biologic response modifiers. J Immunol 153 (1994) 2321-2330
47. Singh V.K., Jacobsen K.O., Grace M.B., Chang C.M., Parekh V.I., Inal C., et al. Administration of 5-androstenediol to mice: pharmacokinetics and gene expression. Exp Mol Pathol 84 (2008) 178-188
48. Singh V.K., Shafran R.L., Jackson III W.E., Seed T.M., and Kumar K.S. Induction of cytokines by radioprotective tocopherol analogs. Exp Mol Pathol 81 (2006) 55-61
49. Singh VK, Brown DS, Kao T. Alpha-tocopherol succinate protects mice from gamma-radiation by induction of granulocyte-colony stimulating factor. Int J Radiat Biol (in press).
50. Ao X., Zhao L., Davis M.A., Lubman D.M., Lawrence T.S., and Kong F.M. Radiation produces differential changes in cytokine profiles in radiation lung fibrosis sensitive and resistant mice. J Hematol Oncol 2 (2009) 6
51. Chang C.M., Limanni A., Baker W.H., Dobson M.E., Kalinich J.F., Jackson III W.E., et al. Bone marrow and splenic granulocyte-macrophage colony-stimulating factor and transforming growth factor-beta mRNA levels in irradiated mice. Blood 86 (1995) 2130-2136
52. Uckun F.M., Souza L., Waddick K.G., Wick M., and Song C.W. In vivo radioprotective effects of recombinant human granulocyte colony-stimulating factor in lethally irradiated mice. Blood 75 (1990) 638-645
53. Waddick K.G., Song C.W., Souza L., and Uckun F.M. Comparative analysis of the in vivo radioprotective effects of recombinant granulocyte colony-stimulating factor (G-CSF), recombinant granulocyte-macrophage CSF, and their combination. Blood 77 (1991) 2364-2371
54. MacVittie T.J., and Farese A.M. Cytokine-based treatment of radiation injury: potential benefits after low-level radiation exposure. Mil Med 167 (2002) 68-70
55. Nishimoto N., and Kishimoto T. Interleukin 6: from bench to bedside. Nat Clin Pract Rheumatol 2 (2006) 619-626
56. Patchen M.L., MacVittie T.J., Williams J.L., Schwartz G.N., and Souza L.M. Administration of interleukin-6 stimulates multilineage hematopoiesis and accelerates recovery from radiation-induced hematopoietic depression. Blood 77 (1991) 472-480
57. Patchen M.L., Fischer R., and MacVittie T.J. Effects of combined administration of interleukin-6 and granulocyte colony-stimulating factor on recovery from radiation-induced hemopoietic aplasia. Exp Hematol 21 (1993) 338-344
58. Ishibashi T., Kimura H., Shikama Y., Uchida T., Kariyone S., Hirano T., et al. Interleukin-6 is a potent thrombopoietic factor in vivo in mice. Blood 74 (1989) 1241-1244
59. Paradkar P.N., Blum P.S., Berhow M.A., Baumann H., and Kuo S.M. Dietary isoflavones suppress endotoxin-induced inflammatory reaction in liver and intestine. Cancer Lett 215 (2004) 21-28
60. Dijsselbloem N., Goriely S., Albarani V., Gerlo S., Francoz S., Marine J.C., et al. A critical role for p53 in the control of NF-kappaB-dependent gene expression in TLR4-stimulated dendritic cells exposed to genistein. J Immunol 178 (2007) 5048-5057
61. Grdisa M., and White M.K. Expression of glyceraldehyde-3-phosphate dehydrogenase during differentiation of HD3 cells. Eur J Cell Biol 71 (1996) 177-182
62. Tolentino P.J., Dikkes P., Tsuruda L., Ebert K., Fink J.S., Villa-Komaroff L., et al. Quantitative analysis of the expression of a VIP transgene. Brain Res Mol Brain Res 33 (1995) 47-60
63. Grace M.B., Blakely W.F., and Landauer M.R. Genistein-induced alterations of radiation-responsive gene expression. Radiat Meas 42 (2007) 1152-1157
64. Chakraborty A., White S.M., Schaefer T.S., Ball E.D., Dyer K.F., and Tweardy D.J. Granulocyte colony-stimulating factor activation of Stat3 alpha and Stat3 beta in immature normal and leukemic human myeloid cells. Blood 88 (1996) 2442-2449
65. Gong L., Li Y., Nedeljkovic-Kurepa A., and Sarkar F.H. Inactivation of NF-kappaB by genistein is mediated via Akt signaling pathway in breast cancer cells. Oncogene 22 (2003) 4702-4709